ASA: Green Light Therapy for Pain-Related Anxiety Studied in Fibromyalgia
TUESDAY, Nov. 1, 2022 (HealthDay News) — Green light therapy might decrease anxiety, particularly fear-based anxiety, in patients with fibromyalgia and reduce the use of opioids to manage chronic pain, according to a study presented at the annual mee…
Learn MoreASA: Same-Day Hip, Knee Replacement Feasible for Selected Patients
TUESDAY, Nov. 1, 2022 (HealthDay News) — Despite the pandemic and same-day admission limitations, effective multidisciplinary collaborations within Enhanced Recovery After Surgery (ERAS) pathways can improve services and provide continuity of care fo…
Learn MoreOccupational Exposures Linked to Decline in Lung Capacity
TUESDAY, Nov. 1, 2022 (HealthDay News) — Workplace exposure to gases, dusts, fumes, and solvents is linked to declines in lung capacity, according to a systematic review and meta-analysis published online Oct. 24 in Occupational & Environmental Medic…
Learn MoreHormonal Therapy Won’t Prevent Chronic Ills After Menopause: Expert Panel
TUESDAY, Nov. 1, 2022 (HealthDay News) — Experts are once again advising doctors and women against using menopausal hormone therapy to ward off chronic diseases — 20 years after a landmark trial dashed those hopes.In updated recommendations, the U.S…
Learn MoreAlcohol to Blame for 1 in 5 Young Adult Deaths in U.S.
TUESDAY, Nov. 1, 2022 (HealthDay News) — For anyone who thinks alcoholism isn’t a deadly disease, a new government report shows alcohol abuse caused nearly 13% of deaths in American adults under 65 between 2015 and 2019.The statistics were even more …
Learn MoreAHA News: Heart Inflammation Risk Remains Rare After Third COVID-19 Vaccine Dose
TUESDAY, Nov. 1, 2022 (American Heart Association News) — A third dose of the Moderna or Pfizer COVID-19 vaccine poses no more risk of heart inflammation than a second dose, a large study suggests. The findings could help allay concerns about risk go…
Learn MoreAHA News: El riesgo de inflamación cardíaca sigue siendo raro tras la tercera dosis de la vacuna contra COVID-19
MARTES, 1 de noviembre de 2022 (American Heart Association News) — Una tercera dosis de las vacunas de Moderna o Pfizer contra el COVID-19 no representa más riesgo de inflamación del corazón que la segunda dosis, sugiere un extenso estudio. Las concl…
Learn MoreImpact of Racism Could Slow Recovery After Heart Attack
TUESDAY, Nov. 1, 2022 (HealthDay News) — Discrimination doesn’t just cause emotional pain in the moment, it may affect a victim’s physical recovery from a heart attack, new research suggests.In studying more than 2,600 heart attack survivors between …
Learn More